Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net Sales	$ 40,718,188	$ 20,139,849
Cost of Goods Sold	32,891,688	16,101,555
Gross Profit	7,826,500	4,038,294
Operating Expenses
Research and development	552,220	319,167
Selling general and administrative	20,369,810	14,804,068
Loss on impairment of goodwill and intangible assets	6,473,310	6,993,075
Total Operating Expenses	27,395,340	22,116,310
Operating Loss	(19,568,840)	(18,078,016)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	2,738	58,276
Interest expense	(1,741,976)	(290,341)
Loss on change in Fair Market Value of Contingent Consideration		(240,000)
Gain on Settlement of Contingent Consideration (Note 2)	7,045,936	1,700,000
Other Income	261,840	274,764
Gain on settlement of debt	796,450
Total Other Income (Expense)	6,364,988	1,502,699
Loss Before Provision for Income Taxes	(13,203,852)	(16,575,317)
Benefit from Income Taxes
Net Loss	(13,203,852)	(16,575,317)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(1,618,981)	(1,449,000)
Net Loss attributable to common stockholders	$ (14,822,833)	$ (18,024,317)
Basic Loss Per Common Share (in Dollars per share)	$ (40)	$ (176.64)
Weighted Average Shares Outstanding - basic (in Shares)	370,571	102,040